IperionX Ltd Files 6-K with ASX Regulatory Filing

Ticker: IPX · Form: 6-K · Filed: Jun 4, 2024 · CIK: 1898601

Iperionx LTD 6-K Filing Summary
FieldDetail
CompanyIperionx LTD (IPX)
Form Type6-K
Filed DateJun 4, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, exhibit

Related Tickers: IPX

TL;DR

IperionX filed a 6-K with an ASX regulatory filing attached. Check ASX for details.

AI Summary

On June 4, 2024, IperionX Limited filed a Form 6-K, reporting a regulatory filing with the Australian Securities Exchange as Exhibit 99.1. The company, formerly known as Hyperion Metals Ltd, is incorporated in North Carolina and has a fiscal year end of June 30.

Why It Matters

This filing indicates IperionX is providing updated information to the ASX, which could contain material developments relevant to investors.

Risk Assessment

Risk Level: low — This is a routine filing reporting an exhibit, not detailing specific financial events or material changes.

Key Players & Entities

FAQ

What is the primary purpose of this Form 6-K filing?

The primary purpose of this Form 6-K is to report a regulatory filing made by IperionX Limited with the Australian Securities Exchange, included as Exhibit 99.1.

What was IperionX Limited's former name?

IperionX Limited's former name was Hyperion Metals Ltd.

When is IperionX Limited's fiscal year end?

IperionX Limited's fiscal year end is June 30.

Where is IperionX Limited's principal executive office located?

IperionX Limited's principal executive office is located at 129 W Trade Street, Suite 1405, Charlotte, North Carolina.

What exhibit is included with this Form 6-K?

Exhibit 99.1, a Regulatory Filing with the Australian Securities Exchange, is included with this Form 6-K.

Filing Stats: 156 words · 1 min read · ~1 pages · Grade level 15 · Accepted 2024-06-04 15:09:15

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 Date: June 4, 2024 Commission File Number: 001-41338 IperionX Limited (Translation of registrant's name into English) 129 W Trade Street, Suite 1405 Charlotte, North Carolina (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX The following exhibits are filed as part of this Form 6-K: Exhibit Description 99.1 Regulatory Filing with the Australian Securities Exchange SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. IPERIONX LIMITED (registrant) Date: June 4, 2024 By: /s/ Marcela Castro Name: Marcela Castro Title: Chief Financial Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing